Loading…
Close iconClose icon DarkLight mode

Find us quickly

130 Wood Street, London, EC2V 6DL
enquiries@buzzacott.co.uk    T +44 (0)20 7556 1200

Google map screengrab

Investigating premiums paid to acquire control: evidence from UK transactions

The existence and size of a ‘control premium’ has been an ongoing debate for a long time. In this piece we consider the evidence for its existence, along with what this might tell us as to how to reflect this within an assessment of the value of equity.

In performing a valuation of an equity interest in a privately held business (typically shares in a private company), it is generally accepted practice to consider the application of a “control premium”. This is the premium which may be paid to acquire an individual share in a transaction where the purchaser obtains a material degree of control over a business, over and above the price of a share that doesn’t convey such benefit.

The existence of such a premium may arguably be evidenced by premiums paid in take-private deals, where a listed company is acquired by another entity and its shares de-listed. Such offers tend to be announced at a significant premium to the share price prevailing prior to the announcement of the offer, suggesting that obtaining control is perceived to be more valuable (all other things being equal) relative to passive ownership of the shares, i.e. simply holding them for dividends and future capital growth.

This intuitively makes sense, as through obtaining control an acquirer will be able to determine the direction of the business, make decisions on appointments to the Board of the company, and so on. Such options are not available to a minority shareholder, who would otherwise need to persuade other shareholders to act in concert with them to effect any change to the business.

About the authors

David Stears

+44 (0)20 7710 3286
stearsd@buzzacott.co.uk
LinkedIn

Ashleigh Barghuti

+44 (0)20 3972 6616
barghutia@buzzacott.co.uk
LinkedIn

In performing a valuation of an equity interest in a privately held business (typically shares in a private company), it is generally accepted practice to consider the application of a “control premium”. This is the premium which may be paid to acquire an individual share in a transaction where the purchaser obtains a material degree of control over a business, over and above the price of a share that doesn’t convey such benefit.

The existence of such a premium may arguably be evidenced by premiums paid in take-private deals, where a listed company is acquired by another entity and its shares de-listed. Such offers tend to be announced at a significant premium to the share price prevailing prior to the announcement of the offer, suggesting that obtaining control is perceived to be more valuable (all other things being equal) relative to passive ownership of the shares, i.e. simply holding them for dividends and future capital growth.

This intuitively makes sense, as through obtaining control an acquirer will be able to determine the direction of the business, make decisions on appointments to the Board of the company, and so on. Such options are not available to a minority shareholder, who would otherwise need to persuade other shareholders to act in concert with them to effect any change to the business.

Measuring the quantum of the control premium

Measuring the quantum of the control premium

As noted above, take-private deals provide us with a source of evidence for the existence of the control premium. Similarly, they would also be able to provide a guideline as to the quantum of such a premium.

The benefits of using previously listed companies in this way (as opposed to acquisitions of private companies) is that the market capitalisation of the target company – which in turn is derived from trades in small parcels of its shares – provides us with a reliable source of market values immediately prior to any announcement. The value of a private company’s shares before a takeover however – in the absence of any contemporaneous trade in those shares (which is true in most cases) – can only be estimated.

We do note here that this does not constitute a perfect comparison however, owing to both the role of synergies and the possibility of selection bias – which may serve to inflate the observed premium. 

With regard to the former, it is entirely possible that an acquirer may have been willing to pay an additional amount for the acquisition to be able to access what they considered to be even more valuable synergies from a combined business. This would have the effect of inflating any observed premium, meaning that the quantum of the observed premium would arguably not then be purely about the price paid for control.

Selection bias may arise because not all listed companies get taken over, and as such we can only draw observations from those companies that are acquired: it may be therefore that there is a natural bias arising as those entities subject to takeovers are those which are perceived to be significantly undervalued. Accordingly, while an acquirer may be willing to pay a premium for a more ‘fully’ valued business, that premium may be so small that it would not be considered worthwhile to make such an attempt because of the greater risk of the deal falling through. The implication of this therefore is that the premiums observed (all other things being equal) may tend to be large, relative to the average which would be observed under the hypothetical scenario that all public companies ultimately became subject to a takeover.

Against these upward pressures on the observed premiums, there may be a degree of ‘offset’ arising from the impact of relative liquidity. By taking a company private, an acquirer loses the ability to quickly realise the value of their investment in the target company (which it should be noted is a benefit available to individual holders of the shares ahead of any deal). The liquid nature of listed shares – all other things being equal – would have the effect of inflating share values relative to a comparable holding in a private company. This in turn suggests that the control premium paid by the acquirer may in effect be larger, as they are acquiring shares which will lose this liquidity benefit subsequent to the deal.

Other factors which may conceivably impact upon observed premiums are market conditions prevailing at the time, the industry sector, the objectives of the acquirer, competitive tension in the bidding process and the size of the transaction – although again it is difficult to control for these factors.

Noting the above, and in common with any attempt to use market benchmarks to perform a valuation, our assessment of an applicable “control premium“ should be considered carefully, and the limitations of our study acknowledged, owing to the volume of variables at play. However, it should be noted that any attempt to assess a meaningful measure of control premium will face the same or similar obstacles, and so in our view this remains a useful guide for consideration of this very subjective area.

Our findings

Our findings

The Buzzacott Valuations team’s review of control premiums paid in take-privates in the UK looks back at the past five years (specifically between 1 January 2018 and 31 December 2022). [1]

Our analysis covers premiums observed across 182 M&A transactions in the UK over that period. In performing our work, we have considered trends that may exist by year, by industry, and whether there was any private equity involvement (either as the buyer or seller) in the transaction or not.

Our analysis is based on prevailing share prices at intervals of one day, one week and one month prior to the announcement date. This allows us to consider the potential impact of rumours of the takeover, which may circulate in the run-up to deal announcement. We have also looked exclusively at median average observations, to avoid the distorting impact of statistical outliers in our sample on mean averages.

Observed premiums by year

Acquisition premiums have somewhat varied across the five-year period, with our median observation ranging between 29% and 43% over prevailing share prices one month prior to the transaction announcement date. This is illustrated within the chart below, which shows the interquartile ranges in each year (within the box), the median lines and the ranges of observed premiums / discounts (which, excluding clear statistical outliers, fall within the ranges illustrated by the ‘whiskers’).

alt

 

Observed premiums by sector 

In contrast to the acquisition data by year, there are significant fluctuations across the different sectors. Over the five-year period the Technology, Media & Telecommunications sector had the highest amount of transactions (at 43) which is unsurprising given that this sector is typically seen as a high-growth area, with lots of opportunity to build businesses with additional capital. 

The highest acquisition premiums were observed in the healthcare sector, whilst the lowest premiums were seen in transport and utilities. The high premiums were driven primarily by acquisitions in biotech & pharmaceutical companies, suggesting that access to intellectual property (and the synergies that may be generated) could be a key factor in driving this premium. At the other end, the transport and utilities sectors tend to include companies that have more predictable and flat growth, which tend to attract much more in the way of institutional capital looking for stable returns.

 

Observed premiums with/without PE involvement 

Finally, looking at the difference between whether the transaction involved buyers from private equity or not, we have observed that transactions with PE involvement had higher acquisition premiums (at a median of 43.3%) opposed to a median of 35.7% where there was no PE involvement amongst the investors.  In private equity transactions, synergies play less of a part than they would in a trade sale (where operations may be combined) – but acting against this, private equity acquirers would be more opportunistic in seeking out undervalued firms and may be able to deploy capital to build or turnaround target businesses that standalone entities would not have access to.

 

How we can help you

How can Buzzacott assist you?

The evidence from take-private deals points to the existence of a control premium, although the quantum of such a premium may vary widely from case to case and the fact that this evidence itself may be distorted by factors such as selection bias. The Valuations team at Buzzacott are experienced in making such independent judgements with reference to observable evidence in their valuations of businesses and equity for commercial, regulatory and contentious purposes, across a wide variety of sectors. By utilising market evidence in support of our assumptions (while acknowledging the limitations of such studies) we are able to provide robust and defensible opinions which stand up to external scrutiny.


[1] Underlying data sourced from S&P Capital IQ Pro.

Speak to an expert
Close iconClose icon backback
Your search for "..."
did not yield any results.
... results for "..."
Search Tags